Minimally invasive hepatectomy: Modulation of systemic reactions to operation or laparoscopic approach?

Surgery

Volumn 131, Issue 1 SUPPL., 2002, Pages

  Shimada, Mitsuo ^a   Harimoto, Norifumi ^a   Maehara, Shin ichiro ^a   Tsujita, Eiji ^a   Rikimaru, Tatsuya ^a   Yamashita, Yo Ichi ^a   Tanaka, Shinji ^a   Shirabe, Ken ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; METHYLPREDNISOLONE; NAFAMSTAT MESILATE; PROSTANOID; PROTEINASE INHIBITOR; THROMBOXANE A2; THROMBOXANE SYNTHASE INHIBITOR;

ARTICLE; BACTERIAL TRANSLOCATION; BLOOD CLOTTING; CYTOKINE PRODUCTION; FIBRINOLYSIS; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LIVER INJURY; LIVER RESECTION; MINIMALLY INVASIVE SURGERY; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; SURGICAL STRESS; THORACOSCOPE; TREATMENT OUTCOME;

EID: 0036169606     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2002.120116     Document Type: Article

References (55)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensns Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
2. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study
3. Estimation of physiologic ability and surgical stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery
4. A new approach for liver surgery: Transdiaphragmatic hepatectomy for cirrhotic patients with hepatocellular carcinoma
5. A thoracoabdominal hepatectomy and a transdiaphragmatic hepatectomy for patient with cirrhosis and hepatocellular carcinoma
6. Modulation of coagulation and fibrinolysis in hepatic resection; a randomized prospective control study using antithrombin III concentrates
7. Effect of nafamostat mesilate on coagulation and fibrinolysis in hepatic resection
8. Initiation of a fibrinolytic system in hepatic resection: The roles of tissue-type plasminogen activator and plasminogen activator inhibitor-1
9. Changes of regulating blood coagulation in hepatic resection with special references to soluble thrombomodulin and Protein C
10. The significance of tissue-type plasminogen activator for pretransplant assessment of liver graft viability: Analysis of effluent from the graft in rats
11. Coagulopathy following major liver resection: The effect of rBPI21 and the role of decreased synthesis of regulating proteins by the liver
12. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers
13. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection
14. Effects of nafamostat mesilate, a synthetic protease inhibitor, on immunity, and coagulation after hepatic resection
15. The role of prostaglandins in hepatic resection
16. The role of the spleen, especially regarding changes in both thromboxane A2 and the remnant liver dysfunction after extensive hepatectomy
17. Thromboxane synthesizing system in rat liver
18. Prostaglandin and thromboxane synthesizing activity in isolated murine hepatocytes and nonparenchymal liver cells
19. A thromboxane A2 synthetase inhibitor, OKY-046, reduces liver damage in hepatectomy
20. The role of prostanoid in hepatic damage during hepatectomy
21. Pathophysiology of dogs after 84% hepatectomy with emphasis on prostaglandin metabolites and the effect of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analog
22. The role of interleukin-6, interleukin-1b, tumor necrosis factor-a, and endotoxin in hepatic resection
23. Cytokine gene expression in liver following minor or major hepatectomy in rat
24. The serum interleukin 8 level reflects hepatic mitochondrial redox state in hyperthermochemohypoxic isolated liver perfusion with use of a venovenous bypass
25. Systemic cytokine response to hepatic resections under total vascular exclusion
26. Is major liver surgery associated with an increased systemic inflammatory response? A prospective comparison of hemihepatectomy and other major abdominal surgery
27. Effect of TNF gene depletion on liver regeneration after partial hepatectomy in mice
28. Normal pharmacologically-induced, but decreased regenerative liver growth in interleukin-6-deficient "IL-6 knockout" mice
29. Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration
30. Correlation between human hepatocyte growth factor and interleukin-6 concentrations after surgery
31. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor
32. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice
33. Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice
34. The effect of a perioperative steroid pulse on surgical stress in hepatic resection
35. Effects of preoperative steroid administration on surgical stress in hepatic resection: Prospective randomized trial
36. Impaired systemic immunity and frequent infection in patients with candida antigen after hepatectomy
37. Effects of perioperative protease inhibitor on inflammatory cytokines and acute-phase proteins in patients with hepatic resection
38. Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer
39. Preoperative high dose methylprednisolone improves patients' outcome after abdominal surgery
40. The effect of preoperative high dose methylprednisolone in attenuating the metabolic response after oesophageal resection
41. Role of adhesion molecule expression and their soluble fractions in hepatic resection
42. Laparoscopic hepatic resection for hepatocellular carcinoma
43. Laparoscopic partial hepatectomy and left lateral segmentectomy: Technique and results of a clinical series
44. Laparoscopic partial hepatectomy
45. Laparoscopic anatomical hepatic resection. Report of four left lobectomies for solid tumors
46. Liver resection with the water jet: Conventional and laparoscopic surgery
47. Laparoscopic hepatic resection: A new and safe procedure by abdominal wall lifting method
48. Current position of advanced laparoscopic surgery of the liver
49. Laparoscopic liver resection compared with conventional partial hepatectomy - A prospective analysis
50. Laparoscopic liver resections: A feasibility study in 30 patients
51. Early experience with laparoscopic approach for solid liver tumors: Initial 16 cases
52. Laparoscopic hepatectomy: New approach for hepatocellular carcinoma
53. Hand-assisted laparoscopic liver resection: Lessons from an initial experience
54. Hepatectomy
55. Laparoscopic hepatectomy for hepatocellular carcinoma